Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation
This study has been completed.
Study NCT00399542 Information provided by Sucampo Pharmaceuticals, Inc.
First Received on November 13, 2006. Last Updated on June 2, 2010
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Irritable Bowel Syndrome
More general conditions related to this trial
Colonic Diseases, Functional
Digestive System Diseases
Signs and Symptoms
Signs and Symptoms, Digestive
Interventions listed in this trial
Sponsors listed in this trial
Sucampo Pharmaceuticals, Inc.
Takeda Pharmaceutical Company Limited
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers